Russell Investments Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
WA
Russell Investments Group's DYN Position: Q2 2026 in Review
Russell Investments Group increased its Dyne Therapeutics (DYN) stake by 164% in Q2 2026, buying an estimated $1.22M and bringing the position to 105,553 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.
Russell Investments Group first reported a position in DYN in Q1 2021 and has held it in 17 quarters since. The position peaked at $4.54M in Q4 2025. 76 funds tracked by Wall St. Rank hold DYN as of Q2 2026.
- Russell Investments Group held 105,553 shares of Dyne Therapeutics worth $2.34M as of Q2 2026.
- Russell Investments Group bought 65,517 Dyne Therapeutics shares in Q2 2026, an estimated $1.22M.
- Dyne Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1994 holding.
- Russell Investments Group first reported a position in Dyne Therapeutics in Q1 2021 and has held it in 17 quarters since.
- Russell Investments Group's Dyne Therapeutics position peaked at $4.54M in Q4 2025.
- 76 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.